ALK germline mutations in patients with neuroblastoma: A rare and weakly penetrant syndrome

European Journal of Human Genetics

Volumn 20, Issue 3, 2012, Pages 291-297

  Bourdeaut, Franck ^a,b   Ferrand, Sandrine ^a   Brugières, Laurence ^c   Hilbert, Marjorie ^d   Ribeiro, Agnès ^a   Lacroix, Ludovic ^c   Bénard, Jean ^c   Combaret, Valérie ^e   Michon, Jean ^a   Valteau Couanet, Dominique ^c   Isidor, Bertrand ^b   Rialland, Xavier ^f   Poirée, Maryline ^g   Defachelles, Anne Sophie ^h   Peuchmaur, Michel ⁱ   Schleiermacher, Gudrun ^a   Pierron, Gaëlle ^a   Gauthier Villars, Marion ^a   Janoueix Lerosey, Isabelle ^a   Delattre, Olivier ^a  

^a INSTITUT CURIE   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e CENTRE LÉON BÉRARD   (France)

^f ANGERS UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY HOSPITAL OF NICE   (France)

^h CENTRE OSCAR LAMBRET   (France)

ⁱ SORBONNE UNIVERSITÉ   (France)

Author keywords

ALK; neuroblastoma; predisposition

Indexed keywords

DNA;

AGE; ALK GENE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC SCREENING; HUMAN; MALE; NEUROBLASTOMA; NEWBORN; ONSET AGE; PERINATAL PERIOD; PRIORITY JOURNAL;

BASE SEQUENCE; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HOMEODOMAIN PROTEINS; HUMANS; INFANT; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASMS, MULTIPLE PRIMARY; NEUROBLASTOMA; PEDIGREE; RECEPTOR PROTEIN-TYROSINE KINASES; TRANSCRIPTION FACTORS;

EID: 84857190916     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2011.195     Document Type: Article

References (29)

1. Li FP, Fraumeni Jr JF: Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst 1969; 43: 1365-1373.
2. Knudson Jr AG: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68: 820-823.
3. DeBaun MR, Niemitz EL, McNeil DE, Brandenburg SA, Lee MP, Feinberg AP: Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet 2002; 70: 604-611. (Pubitemid 34177916)
4. Scott RH, Douglas J, Baskcomb L et al: Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor. Nat Genet 2008; 40: 1329-1334.
5. Lim DH, Maher ER: Genomic imprinting syndromes and cancer. Adv Genet 2010; 70: 145-175.
6. Brichard B, Heusterspreute M, De Potter P et al: Unilateral retinoblastoma, lack of familial history and older age does not exclude germline RB1 gene mutation. Eur J Cancer 2006; 42: 65-72. (Pubitemid 41814533)
7. Garre ML, Cama A, Bagnasco F et al: Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome-a new clinical perspective. Clin Cancer Res 2009; 15: 2463-2471.
8. Knudson Jr AG, Strong LC: Mutation and cancer: neuroblastoma and pheochromocytoma. Am J Hum Genet 1972; 24: 514-532.
9. Maris JM, Kyemba SM, Rebbeck TR et al: Molecular genetic analysis of familial neuroblastoma. Eur J Cancer 1997; 33: 1923-1928. (Pubitemid 28123426)
10. Maris JM, Kyemba SM, Rebbeck TR et al: Familial predisposition to neuroblastoma does not map to chromosome band 1p36. Cancer Res 1996; 56: 3421-3425. (Pubitemid 26251630)
11. Amiel J, Laudier B, Attie-Bitach T et al: Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet 2003; 33: 459-461. (Pubitemid 36390004)
12. Trochet D, Bourdeaut F, Janoueix-Lerosey I et al: Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. Am J Hum Genet 2004; 74: 761-764. (Pubitemid 38420106)
13. Mosse YP, Laudenslager M, Khazi D et al: Germline PHOX2B mutation in hereditary neuroblastoma. Am J Hum Genet 2004; 75: 727-730. (Pubitemid 39244788)
14. Berry-Kravis EM, Zhou L, Rand CM, Weese-Mayer DE: Congenital central hypoventilation syndrome: PHOX2B mutations and phenotype. Am J Respir Crit Care Med 2006; 174: 1139-1144. (Pubitemid 44772085)
15. McConville C, Reid S, Baskcomb L, Douglas J, Rahman N: PHOX2B analysis in non-syndromic neuroblastoma cases shows novel mutations and genotype-phenotype associations. Am J Med Genet A 2006; 140: 1297-1301. (Pubitemid 43835416)
16. Raabe EH, Laudenslager M, Winter C et al: Prevalence and functional consequence of PHOX2B mutations in neuroblastoma. Oncogene 2008; 27: 469-476.
17. van Limpt V, Schramm A, van Lakeman A et al: The Phox2B homeobox gene is mutated in sporadic neuroblastomas. Oncogene 2004; 23: 9280-9288. (Pubitemid 40069698)
18. Janoueix-Lerosey I, Lequin D, Brugieres L et al: Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature 2008; 455: 967-970.
19. Mosse YP, Laudenslager M, Longo L et al: Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 2008; 455: 930-935.
20. Caren H, Abel F, Kogner P, Martinsson T: High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours. Biochem J 2008; 416: 153-159.
21. Chen Y, Takita J, Choi YL et al: Oncogenic mutations of ALK kinase in neuroblastoma. Nature 2008; 455: 971-974.
22. De Brouwer S, De Preter K, Kumps C et al: Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification. Clin Cancer Res 2010; 16: 4353-4362.
23. George RE, Sanda T, Hanna M et al: Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature 2008; 455: 975-978.
24. Roshkow JE, Haller JO, Berdon WE, Sane SM: Hirschsprung's disease, Ondine's curse, and neuroblastoma-manifestations of neurocristopathy. Pediatr Radiol 1988; 19: 45-49. (Pubitemid 19011923)
25. Kushner BH, Gilbert F, Helson L: Familial neuroblastoma. Case reports, literature review, and etiologic considerations. Cancer 1986; 57: 1887-1893. (Pubitemid 16112007)
26. Abbaszadeh F, Barker KT, McConville C, Scott RH, Rahman N: A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma. Fam Cancer 2010; 9: 425-430.
27. Matera I, Bachetti T, Puppo F et al: PHOX2B mutations and polyalanine expansions correlate with the severity of the respiratory phenotype and associated symptoms in both congenital and late onset Central Hypoventilation syndrome. J Med Genet 2004; 41: 373-380. (Pubitemid 38608521)
28. Murugan AK, Xing M: Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene. Cancer Res 2011; 71: 4403-4411.
29. de Pontual L, Kettaneh D, Gordon C et al: Germline gain-of-function mutations of ALK disrupt central nervous system development. Hum Mutat 2011; 32: 272-276.